Honz Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	17.27	59.75	113.19	145.09	270.11	258.99
Cash & Short-Term Investments	17.27	59.75	113.19	145.09	270.11	258.99
Cash Growth	-81.42%	-47.21%	-21.99%	-46.28%	4.29%	-0.02%
Accounts Receivable	41.88	44.16	68.77	139.63	73.14	153.16
Other Receivables	10.72	6.38	25.92	39.26	52.59	66.3
Receivables	52.6	50.54	94.7	178.89	125.73	219.45
Inventory	160.33	160.12	187.33	236.43	170.4	197.87
Prepaid Expenses	-	0.34	0.38	0.43	-	-
Other Current Assets	38.61	33.73	47.19	48.51	104.22	43.59
Total Current Assets	268.81	304.48	442.78	609.35	670.46	719.9
Property, Plant & Equipment	705.01	715.17	1,022	987.29	950.53	989.88
Long-Term Investments	4.97	4.97	4.97	5.3	5.95	10.98
Goodwill	8.3	8.3	13.5	20.05	18.89	18.89
Other Intangible Assets	61.6	63.71	139.86	160.33	167.55	202.68
Long-Term Deferred Tax Assets	64.93	70.74	51.59	42.3	47.9	25.94
Long-Term Deferred Charges	56.14	55.87	77.87	81.02	75.21	72.86
Other Long-Term Assets	567.47	567.76	223.65	259.98	351.98	417.66
Total Assets	1,737	1,791	1,976	2,166	2,288	2,459
Accounts Payable	60.78	52.71	66.26	78.02	57.4	112.33
Accrued Expenses	7.41	94.94	64.8	44.29	43.8	30.47
Short-Term Debt	153.55	166.05	171.08	139.89	133.22	148.5
Current Portion of Long-Term Debt	81.24	80.57	110.51	36.77	107.05	100.78
Current Portion of Leases	-	0.6	0.46	-	-	-
Current Income Taxes Payable	12.93	3.02	3.03	16.27	3.77	4.16
Current Unearned Revenue	14.52	24.53	42.21	10.79	95.66	26.1
Other Current Liabilities	212.06	161.06	62.39	54.56	63.61	62.59
Total Current Liabilities	542.49	583.49	520.74	380.59	504.51	484.92
Long-Term Debt	181.82	181.82	210	324.98	342.85	343.52
Long-Term Leases	17.85	17.66	18.65	-	-	-
Long-Term Unearned Revenue	53.15	53.89	51.63	48.18	51	35.61
Long-Term Deferred Tax Liabilities	32.87	32.93	34.58	33.86	34.6	41.09
Total Liabilities	828.17	869.79	835.59	787.6	932.96	905.14
Common Stock	455.12	455.12	455.12	450	450	450
Additional Paid-In Capital	842.99	842.99	842.99	836.49	818.96	818.96
Retained Earnings	-476.22	-464.47	-234.34	6.28	-5.25	182.34
Comprehensive Income & Other	66.05	66.07	51.73	51.98	52.47	52.65
Total Common Equity	887.94	899.71	1,116	1,345	1,316	1,504
Minority Interest	21.12	21.51	25.4	33.26	39.33	49.69
Shareholders' Equity	909.06	921.22	1,141	1,378	1,356	1,554
Total Liabilities & Equity	1,737	1,791	1,976	2,166	2,288	2,459
Total Debt	434.46	446.69	510.7	501.64	583.12	592.8
Net Cash (Debt)	-417.19	-386.94	-397.52	-356.55	-313.01	-333.8
Net Cash Per Share	-0.92	-0.85	-0.88	-0.79	-0.70	-0.74
Filing Date Shares Outstanding	455.12	455.12	455.12	450	450	450
Total Common Shares Outstanding	455.12	455.12	455.12	450	450	450
Working Capital	-273.68	-279.01	-77.95	228.76	165.95	234.98
Book Value Per Share	1.95	1.98	2.45	2.99	2.92	3.34
Tangible Book Value	818.04	827.7	962.15	1,164	1,130	1,282
Tangible Book Value Per Share	1.80	1.82	2.11	2.59	2.51	2.85
Buildings	-	739.95	1,054	872.16	860.84	362.09
Machinery	-	403.6	398.28	383.47	381.58	289.25
Construction In Progress	-	18	12.03	145.62	59.59	659.28